12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Gainers

  • Aridis Pharmaceuticals ARDS shares increased by 98.9% to $0.37 during Wednesday's pre-market session. The market value of their outstanding shares is at $13.2 million.
  • VistaGen Therapeutics VTGN stock increased by 38.98% to $0.19. The market value of their outstanding shares is at $40.8 million.
  • Marker Therapeutics MRKR shares increased by 30.83% to $1.74. The market value of their outstanding shares is at $15.3 million.
  • Tenax Therapeutics TENX stock moved upwards by 25.06% to $0.4. The market value of their outstanding shares is at $8.7 million.
  • Freeline Therapeutics FRLN shares moved upwards by 15.99% to $2.9. The market value of their outstanding shares is at $12.5 million. The company's, Q1 earnings came out yesterday.
  • Akebia Therapeutics AKBA shares rose 15.79% to $1.11. The market value of their outstanding shares is at $206.3 million.

Losers

  • Belite Bio BLTE stock fell 44.0% to $13.39 during Wednesday's pre-market session. The market value of their outstanding shares is at $337.7 million.
  • Biodexa Pharmaceuticals BDRX shares declined by 32.82% to $0.09. The company's market cap stands at $1.7 million.
  • Bellicum Pharmaceuticals BLCM shares decreased by 25.09% to $0.57. The company's market cap stands at $5.4 million.
  • NeuBase Therapeutics NBSE stock decreased by 19.93% to $0.14. The company's market cap stands at $4.7 million.
  • Aclarion ACON stock declined by 15.86% to $0.88. The market value of their outstanding shares is at $6.9 million.
  • Phio Pharma PHIO stock decreased by 13.9% to $3.47. The company's market cap stands at $5.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!